Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.54 USD | +4.65% | +2.65% | -12.99% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.99% | 2.18B | |
+57.05% | 59.34B | |
+43.17% | 40.24B | |
-5.07% | 39.88B | |
-5.56% | 28.55B | |
+14.85% | 27.26B | |
-21.33% | 19.23B | |
+32.02% | 12.61B | |
+2.06% | 12.49B | |
+25.84% | 12.28B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise